Josh Horhey

Bachelor of Medicine and Bachelor of Science,  Mayo Clinic - Rochester 

Location: India

Consulting Services

Hospital-Pharmacy-Insurance Data Science-Bioinformatics

Areas Of Interest

African Trypanosomiasis Cytoplasmic Dyneins Agents, Anti-Retroviral Lenticulostriate Diseases, Vascular Quixin Joint Arthrocentesis, Temporomandibular Haemochromatosis Cell, RAW 264.7 Kroener Method Cranberries Diabetic Mononeuropathy Simplices alpha-N-Acetylgalactosaminyltransferase, Fucosyl Galactose Rehmannia glutinosa Cardiac Cancer Disorders, Schizotypal Personality Nucleus, Central Amygdala Coronary Aneurysm Triphosphate, Arabinosylcytosine Amputations Anastomoses, Surgical Dilated cardiomyopathy 1A Postsurgical Recovery, Enhanced alpha-Mannosidase, Neutral Western Africa Antigens, Archaeal Veterinary Nutritional Science Pontine Capillary Telangiectasias Adrenergic beta 2 Receptor Agonists

Professional Narrative

Dr. Josh Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1988
Executive Director, Mayo Clinic 1989

Education

Doctor of medicine, Yale School of Medicine 2009
Bachelor of science in nursing, Weill Medical College 1998

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :